Improvement of atopic dermatitis with dupilumab occurs equally well across different anatomical regions: data from phase III clinical trials. [electronic resource]
- The British journal of dermatology 07 2019
- 196-197 p. digital
Publication Type: Letter
1365-2133
10.1111/bjd.17703 doi
Antibodies, Monoclonal, Humanized--administration & dosage Clinical Trials, Phase III as Topic Dermatitis, Atopic--diagnosis Humans Interleukin-4 Receptor alpha Subunit--antagonists & inhibitors Severity of Illness Index Skin--drug effects Treatment Outcome